Skip to main content
Premium Trial:

Request an Annual Quote

EpiVax, BioAtla Collaborate on Antibody Screening Technology

NEW YORK (GenomeWeb News) – EpiVax's immunogenicity screening technology will be incorporated into BioAtla's antibody Express Humanization platform under a collaboration announced today.

Providence, RI-based EpiVax has developed in silico tools for the immunogenicity screening of protein therapeutics, immunogenicity mitigation, and T cell-driven vaccine design, while San Diego-based BioAtla's Express Humanization platform "entails synthesizing a combinatorial library of non-human target monoclonal antibodies fused in frame to a validated collection of human frameworks, and screening for binding, function, and expression."

Combining the two companies' technologies, they said, provides a third level clone selection criterion for developing human antibody therapeutics, immunogenicity, thereby expanding the functional selectivity of BioAtla's expression-based humanization process.

Financial and other terms of the deal were not disclosed.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.